Search research articles
Contact Us
Filters
Showing results (131-140 of 515) with videos related to
Page
of 52
Sort By:
Blood
|
May 8, 2004
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
Shaji Kumar, Thomas E Witzig, Michael Timm, et al.
American Journal of Hematology
|
December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?
Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.
Targeted Oncology
|
August 14, 2017
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses
Neeraj Gupta, Huyuan Yang, Michael J Hanley, et al.
The Journal of Applied Laboratory Medicine
|
May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance
Krasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Blood Cancer Journal
|
July 30, 2020
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
Amit Kumar Mitra, Harish Kumar, Vijay Ramakrishnan, et al.
Clinical Advances in Hematology & Oncology : H&O
|
October 7, 2022
Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directions
Dunya Alsomali, Dania Mohty, Martha Grogan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2025
Monoclonal Gammopathies in Africa
Abiola Bolarinwa, Lateef Odukoya, Francis Buadi, et al.
Blood
|
January 22, 2010
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction
Morie A Gertz, Shaji Kumar, Martha Q Lacy, et al.
Oncotarget
|
October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Utkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
Oncotarget
|
August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
Vijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.
Page
of 52
Search research articles
Search
Showing results (131-140 of 515) with videos related to
Sort By:
Page
of 52
Blood
|
May 8, 2004
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
Shaji Kumar, Thomas E Witzig, Michael Timm, et al.
American Journal of Hematology
|
December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?
Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.
Targeted Oncology
|
August 14, 2017
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses
Neeraj Gupta, Huyuan Yang, Michael J Hanley, et al.
The Journal of Applied Laboratory Medicine
|
May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance
Krasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Blood Cancer Journal
|
July 30, 2020
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
Amit Kumar Mitra, Harish Kumar, Vijay Ramakrishnan, et al.
Clinical Advances in Hematology & Oncology : H&O
|
October 7, 2022
Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directions
Dunya Alsomali, Dania Mohty, Martha Grogan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2025
Monoclonal Gammopathies in Africa
Abiola Bolarinwa, Lateef Odukoya, Francis Buadi, et al.
Blood
|
January 22, 2010
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction
Morie A Gertz, Shaji Kumar, Martha Q Lacy, et al.
Oncotarget
|
October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Utkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
Oncotarget
|
August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
Vijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.
Page
of 52